Product Overview: IGF-1 LR3 SATAN PHARMA
IGF-1 LR3 is a synthetic analogue of insulin-like growth factor-1 engineered with enhanced stability and extended half-life characteristics. This modified peptide incorporates amino acid substitutions that reduce binding affinity to IGF binding proteins while maintaining receptor activity, making it a valuable tool for investigating growth factor biology. Researchers at Stroid UK Shop study IGF-1 LR3 to examine cellular growth mechanisms, protein synthesis pathways, and metabolic regulation at the molecular level.
Laboratory Research Applications
In experimental settings, scientists examine IGF-1 LR3 to investigate its interaction with IGF-1 receptors and downstream signalling cascades including PI3K/Akt and MAPK pathways. Research teams analyse how this peptide influences cellular proliferation, differentiation, and survival mechanisms in various tissue models. The compound’s extended pharmacokinetic profile enables researchers to study sustained growth factor signalling effects that differ from native IGF-1. Academic institutions investigate IGF-1 LR3 in muscle biology research, examining its role in satellite cell activation and myofiber development. Scientists studying peptide research compounds often compare IGF-1 LR3 effects with other growth factors to understand tissue-specific responses.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Long R3 Insulin-like Growth Factor-I |
| Molecular Weight | Approximately 9.1 kDa |
| Sequence Length | 83 amino acids |
| Manufacturer | Satan Pharma |
| Storage Conditions | Lyophilised: -20°C; Reconstituted: 2-8°C |
Research laboratories examining growth factor biology frequently evaluate IGF-1 LR3 alongside other selective compounds to understand comparative mechanisms. Advanced studies investigate how IGF-1 LR3 differs from endogenous IGF-1 in receptor binding kinetics, tissue distribution, and cellular response profiles. Researchers utilise this peptide to study growth factor resistance mechanisms and examine how modified growth factors interact with cellular signalling networks.
Compliance and Research Use
Scientists working with research peptides must maintain proper storage conditions and follow institutional protocols for peptide handling. IGF-1 LR3 requires careful reconstitution procedures and sterile handling techniques to preserve biological activity during experimental protocols. This product is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments under appropriate scientific supervision.
